The 42nd annual J.P. Morgan Healthcare Conference started with clear skies and overall optimism from investors. But with Jamie Dimon’s prediction of a recession in 2024 on Tuesday morning, the climate shifted to an on-again,...more
1/12/2024
/ Acquisitions ,
Asset Diversification ,
Chapter 11 ,
Health Technology ,
Healthcare ,
Home Health Care ,
Hospice ,
Initial Public Offering (IPO) ,
Investors ,
JPMorgan Chase ,
Medicaid ,
Mental Health ,
Mergers ,
Pharmaceutical Industry ,
Reimbursements ,
Takeovers ,
Value-Based Care
Following a record-breaking first quarter, merger and acquisition (M&A) activity within the healthcare industry kept pace during the second quarter of 2021, showing no signs of slowing. Although the volume of deal activity...more
8/24/2021
/ Acquisitions ,
Ambulatory Surgery Centers ,
Buyers ,
Coronavirus/COVID-19 ,
Digital Health ,
Health Information Technologies ,
Hospice ,
Hospitals ,
Investors ,
Life Sciences ,
Managed Care Contracts ,
Mergers ,
Pharmaceutical Industry ,
Physicians ,
Private Equity ,
Private Equity Funds ,
Special Purpose Acquisition Companies (SPACs)
For the fifth consecutive year, the Bass, Berry & Sims Healthcare Private Equity Team hosted BBS Connect, a forum to connect healthcare dealmakers during the annual J.P. Morgan Healthcare Conference.
Over three days –...more